drugset / Trial / NCT05622123
BetaFIT Study: Beta Cell Imaging After Faecal mIcrobiota Transplantation
NaSingle-groupOpen-labelOther
Summary
The main goal is to investigate whether beta cell mass is correlated to beta cell function after autologous faecal microbial transplantation (FMT) in patients with newly diagnosed type 1 diabetes
Timeline
- Start
- 2023-02-23
- Primary completion
- 2024-02-28
- Completion
- 2024-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 68Ga-NODAGA-Exendin-4 | Diagnostic / imaging agent | — | — |